ttlc-iaslc.org

What It Is

TTLC 2026 (Targeted Therapies of Lung Cancer Meeting 2026) is a leading international academic conference organized by the International Association for the Study of Lung Cancer (IASLC). The event is dedicated to advancing lung cancer diagnosis and treatment, bringing together top experts in thoracic oncology from around the world to share the latest breakthroughs in clinical research and targeted therapy.

Key Dimensions

• Course Focus: Deeply focused on medical oncology, especially targeted therapy and cutting-edge clinical research in lung cancer and thoracic malignancies.
• Format: A hybrid “in-person + online” format. The in-person event takes place in Huntington Beach, California, while online participation includes live streaming, recorded replays, and PPT downloads.
• Faculty / Institutional Background: Organized by IASLC, the only global professional association dedicated to lung cancer research. Speakers are internationally renowned researchers and clinicians.
• Accreditation / Certificate: The source text does not mention a completion certificate; the conference primarily serves as a platform for academic exchange and continuing education.
• Language: English, as is standard for international conferences.

Pricing Strategy

The pricing structure is complex and clearly tiered, with substantial discounts for IASLC members:

• In-person Attendance: From early-bird to late registration, members pay $850-$1050, while non-members pay $1000-$1250.
• Online Attendance: $500 for members and $700 for non-members.
• Discounted Groups: For Fellows, medical students, nurses, participants from developing countries, and similar groups, online access is only $150-$200. Patients and caregivers can attend for free if they are members.

Pros and Cons

• Pros: 1. Highly authoritative, with direct access to the latest frontline data in targeted therapy for lung cancer; 2. Very inclusive pricing, especially friendly to early-career researchers, participants from developing countries, and patients; 3. Strong online participation benefits, including replays and PPT downloads.
• Cons: 1. Abstract submission requirements are strict: first authors/presenters are limited to early-career researchers in North America who graduated within the past two years; 2. In-person registration fees may be high for ordinary physicians.

Who It’s For

Thoracic oncologists, clinical and basic researchers, pharmaceutical industry professionals, medical students and Fellows, as well as patients and caregivers interested in the latest advances in targeted therapies for lung cancer.

Access From China

Basic information on the official website can usually be accessed directly, but the online live-streaming platform and replay system may rely on overseas streaming services and carry a risk of being partially restricted in mainland China. It is recommended to test your connection in advance or prepare a proxy tool.